Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis

Shapiro, 2014, Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09., J Antimicrob Chemother, 69, 234, 10.1093/jac/dkt301

Drusano, 1998, Pharmacokinetics and pharmacodynamics of fluoroquinolones., Clin Microbiol Infect, 4, S27, 10.1111/j.1469-0691.1998.tb00692.x

Metlay, 2019, Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America., Am J Respir Crit Care Med, 200, e45, 10.1164/rccm.201908-1581ST

Noreddin, 2005, Pharmacokinetics and pharmacodynamics of the new quinolones., J Pharm Pract., 18, 432, 10.1177/0897190005282397

Rubinstein, 2002, Cardiotoxicity of fluoroquinolones., J Antimicrob Chemother, 49, 593, 10.1093/jac/49.4.593

Briasoulis, 2011, QT prolongation and torsade de pointes induced by fluoroquinolones: infrequent side effects from commonly used medications., Cardiology, 120, 103, 10.1159/000334441

Gorelik, 2019, Fluoroquinolones and cardiovascular risk: a systematic review, meta-analysis and network meta-analysis., Drug Saf, 42, 529, 10.1007/s40264-018-0751-2

Liu, 2017, Fluoroquinolones increase the risk of serious arrhythmias: a systematic review and meta-analysis., Medicine (Baltimore), 96, 10.1097/MD.0000000000008273

Assimon, 2020, Use of QT prolonging medications by hemodialysis patients and individuals without end-stage kidney disease., J Am Heart Assoc, 9, 10.1161/JAHA.120.015969

Makar, 2017, Sudden cardiac death among hemodialysis patients., Am J Kidney Dis, 69, 684, 10.1053/j.ajkd.2016.12.006

Gandhi, 2003, Fluconazole- and levofloxacin-induced torsades de pointes in an intensive care unit patient., Am J Health Syst Pharm, 60, 2479, 10.1093/ajhp/60.23.2479

Altin, 2007, Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event., Can J Cardiol, 23, 907, 10.1016/S0828-282X(07)70850-4

Ray, 2003, Evaluating medication effects outside of clinical trials: new-user designs., Am J Epidemiol, 158, 915, 10.1093/aje/kwg231

Rosenfeld, 2015, Clinical practice guideline (update): adult sinusitis., Otolaryngol Head Neck Surg, 152, S1

Lee, 2021, Appropriate use of short-course antibiotics in common infections: best practice advice from the American College of Physicians., Ann Intern Med, 174, 822, 10.7326/M20-7355

Bleyer, 2006, Characteristics of sudden death in hemodialysis patients., Kidney Int, 69, 2268, 10.1038/sj.ki.5000446

Pun, 2012, Improving ascertainment of sudden cardiac death in patients with end stage renal disease., Clin J Am Soc Nephrol, 7, 116, 10.2215/CJN.02820311

Brookhart, 2006, Variable selection for propensity score models., Am J Epidemiol, 163, 1149, 10.1093/aje/kwj149

Austin, 2009, Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research., Communications Statistics Simulation Computation., 38, 1228, 10.1080/03610910902859574

Lund, 2015, The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application., Curr Epidemiol Rep, 2, 221, 10.1007/s40471-015-0053-5

Fine, 1999, A proportional hazards model for the subdistribution of a competing risk., J Am Stat Assoc., 94, 496, 10.1080/01621459.1999.10474144

Liang, 1986, Longitudinal data analysis using generalized linear models, Biometrika., 73, 13, 10.1093/biomet/73.1.13

Cameron, 2008, Bootstrap-based improvements for inference with clustered errors., Rev Econ Stat., 90, 414, 10.1162/rest.90.3.414

Brookhart, 2013, Propensity score methods for confounding control in nonexperimental research., Circ Cardiovasc Qual Outcomes, 6, 604, 10.1161/CIRCOUTCOMES.113.000359

Taubel, 2014, Thorough QT study of the effect of oral moxifloxacin on QTc interval in the fed and fasted state in healthy Japanese and Caucasian subjects., Br J Clin Pharmacol, 77, 170, 10.1111/bcp.12168

Sugiyama, 2012, Comparison of the effects of levofloxacin on QT/QTc interval assessed in both healthy Japanese and Caucasian subjects., Br J Clin Pharmacol, 73, 455, 10.1111/bcp.2012.73.issue-3

Noel, 2003, Effects of three fluoroquinolones on QT interval in healthy adults after single doses., Clin Pharmacol Ther, 73, 292, 10.1016/S0009-9236(03)00009-2

Bloomfield, 2008, The effect of moxifloxacin on QTc and implications for the design of thorough QT studies., Clin Pharmacol Ther, 84, 475, 10.1038/clpt.2008.33

Taubel, 2010, Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers., Br J Clin Pharmacol, 69, 391, 10.1111/(ISSN)1365-2125

Imbens, 2000, The role of the propensity score in estimating dose-response functions., Biometrika, 87, 706, 10.1093/biomet/87.3.706

Rubinstein, 2001, History of quinolones and their side effects., Chemotherapy, 47, 3, 10.1159/000057838

Alexandrou, 2006, Mechanism of hERG K+ channel blockade by the fluoroquinolone antibiotic moxifloxacin., Br J Pharmacol, 147, 905, 10.1038/sj.bjp.0706678

Kang, 2001, Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG., Mol Pharmacol, 59, 122, 10.1124/mol.59.1.122

Tisdale, 2020, Drug-induced arrhythmias: a scientific statement from the American Heart Association., Circulation, 142, e214, 10.1161/CIR.0000000000000905

Gussak, 2007, Sudden cardiac death in nephrology: focus on acquired long QT syndrome., Nephrol Dial Transplant, 22, 12, 10.1093/ndt/gfl587

Nattel, 2007, Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation., Physiol Rev, 87, 425, 10.1152/physrev.00014.2006

Varró, 2011, Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk., Br J Pharmacol, 164, 14, 10.1111/bph.2011.164.issue-1

Morganroth, 2005, A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia., Chest, 128, 3398, 10.1378/chest.128.5.3398

Jukema, 2019, Prophylactic use of implantable cardioverter-defibrillators in the prevention of sudden cardiac death in dialysis patients., Circulation, 139, 2628, 10.1161/CIRCULATIONAHA.119.039818

United States Renal Data System, 2020, 2020 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States.

2020

2020

United States Renal Data System ESRD. Analytical? methods. 2020. Accessed March 31, 2021. https://adr.usrds.org/2020/end-stage-renal-disease/esrd-analytical-methods

Woosley RL, Heise CW, Gallo T, Tate J, Woosley D Romero KA. QTdrugs list. Accessed January 4, 2021. http://www.CredibleMeds.org